The emerging role of adipokines as mediators of inflammation and immune responses

Cytokine and Growth Factor Reviews

Volumn 18, Issue 3-4, 2007, Pages 313-325

  Lago, Francisca ^a   Dieguez, Carlos ^b   Gómez Reino, Juan ^a   Gualillo, Oreste ^a  

^a Instituto de Salud Carlos III   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Adipokines; Articular degenerative diseases; Atherosclerosis; Immune system; Inflammation

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APELIN; HEPCIDIN; LEPTIN; RESISTIN; UNCLASSIFIED DRUG; VASPIN; VISFATIN;

CYTOKINE PRODUCTION; IMMUNE RESPONSE; INFLAMMATION; LIFESTYLE; METABOLIC SYNDROME X; NUTRITION; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; WHITE ADIPOSE TISSUE;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ATHEROSCLEROSIS; CYTOKINES; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MODELS, BIOLOGICAL; PEPTIDE HORMONES; RECEPTORS, CELL SURFACE; SERPINS;

EID: 34249983235     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2007.04.007     Document Type: Review

References (108)

1. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 6505 (1994) 425-432
2. Otero M., Lago R., Lago F., Casanueva F.F., Dieguez C., Gomez-Reino J.J., et al. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 579 2 (2005) 295-301
3. Trayhurn P., and Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92 3 (2004) 347-355
4. Trayhurn P., and Wood I.S. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 33 Pt 5 (2005) 1078-1081
5. Lau D.C., Dhillon B., Yan H., Szmitko P.E., and Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 288 5 (2005) H2031-H2041
6. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 5091 (1993) 87-91
7. Trayhurn P., Bing C., and Wood I.S. Adipose tissue and adipokines-energy regulation from the human perspective. J Nutr 136 7 (2006) 1935S-1939S
8. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., et al. Role of leptin in the neuroendocrine response to fasting. Nature 382 (1996) 250-252
9. Chan J.L., Heist K., DePaoli A.M., Veldhuis J.D., and Mantzoros C.S. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 111 (2003) 1409-1421
10. Zakrzewska K.E., Cusin I., Sainsbury A., Rohner-Jeanrenaud F., and Jeanrenaud B. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes 46 (1997) 717-719
11. Boden G., Chen X., Kolaczynski J.W., and Polansky M. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Inv 100 (1997) 1107-1113
12. Sarraf P., Frederich R.C., Turner E.M., Ma G., Jaskowiak N.T., Rivet III D.J., et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 185 (1997) 171-175
13. Gualillo O., Eiras S., Lago F., Dieguez C., and Casanueva F.F. Elevated serum leptin concentrations induced by experimental acute inflammation. Life Sci 67 (2000) 2433-2441
14. Blum W.F., Englaro P., Hanitsch S., Juul A., Hertel N.T., Muller J., et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. Clin Endocrinol Metab 82 (1997) 2904-2910
15. Otero M., Lago R., Gomez R., Dieguez C., Lago F., Gomez-Reino J., et al. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 45 8 (2006) 944-950
16. Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem J 393 (2006) 7-20
17. Bates S.H., Stearns W.H., Dundon T.A., Schubert M., Tso A.W., Wang Y., et al. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421 6925 (2003) 856-859
18. Gualillo O., Eiras S., White D.W., Dieguez C., and Casanueva F.F. Leptin promotes the tyrosine phosphorylation of SHC proteins and SHC association with GRB2. Mol Cell Endocrinol 190 (2002) 83-89
19. Prodi F., and Obici S. The brain as a molecular target for diabetic therapy. Endocrinology 147 6 (2006) 2664-2669
20. Bjorbaek C., Elmquist J.K., Frantz J.D., and Flier J.S. The role of SOCS3 in leptin signalling and leptin resistance. J Biol Chem 274 (1999) 30059-30065
21. Kimura M., Tanaka S., Isoda F., Sekigawa K., Yamakawa T., and Sekihara H. T lymphopenia in obese diabetic (db/db) mice is non-selective and thymus independent. Life Sci 62 (1998) 1243-1250
22. Tilg H., and Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6 (2006) 772-783
23. Matarese G., Moschos S., and Mantzoros C.S. Leptin in immunology. J Immunol 174 (2005) 3137-3142
24. Zarkesh-Esfahani H., Pockley G., Metcalfe R.A., Bidlingmaier M., Wu Z., Ajami A., et al. High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol 167 (2001) 4593-4599
25. Mancuso P., Canetti C., Gottschalk A., Tithof P.K., and Peters-Golden M. Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2gamma) protein expression. Am J Physiol Lung Cell Mol Physiol 287 (2004) 497-502
26. Raso G.M., Pacilio M., Esposito E., Coppola A., Di Carlo R., and Meli R. Leptin potentiates IFN-gamma-induced expression of nitric oxide synthase and cyclo-oxygenase-2 in murine macrophage J774A. 1. Br J Pharmacol 137 (2002) 799-804
27. Caldefie-Chezet F., Poulin A., Tridon A., Sion B., and Vasson M.P. Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action?. J Leukoc Biol 69 (2001) 414-418
28. Caldefie-Chezet F., Poulin A., and Vasson M.P. Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic Res 37 (2003) 809-814
29. Tian Z., Sun R., Wei H., and Gao B. Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem Biophys Res Commun 298 (2002) 297-302
30. Lam Q.L.K., Liu S., Cao X., and Lu L. Involvement of leptin signaling in the survival and maturation of bone marrow-derived dendritic cells. Eur J Immunol 36 12 (2006) 3118-3130
31. Farooqi I.S., Matarese G., Lord G.M., Keogh J.M., Lawrence E., Agwu C., et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110 (2002) 1093-1103
32. Lord G.M., Matarese G., Howard J.K., Baker R.J., Bloom S.R., and Lechler R.I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394 (1998) 897-901
33. Howard J.K., Lord G.M., Matarese G., Vendetti S., Ghatei M.A., Ritter M.A., et al. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 104 (1999) 1051-1059
34. Ruter J., Hoffmann T., Demuth H.U., Moschansky P., Klapp B.F., and Hildebrandt M. Evidence for an interaction between leptin, T cell costimulatory antigens CD28, CTLA-4 and CD26 (dipeptidyl peptidase IV) in BCG-induced immune responses of leptin- and leptin receptor-deficient mice. Biol Chem 385 (2004) 537-541
35. Sanna V., Di Giacomo A., La Cava A., Lechler R.I., Fontana S., Zappacosta S., et al. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest 111 (2003) 241-250
36. Faggioni R., Feingold K.R., and Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 14 (2001) 2565-2571
37. Faggioni R., Fantuzzi G., Gabay C., Moser A., Dinarello C.A., Feingold K.R., et al. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 276 (1999) 136-142
38. Williams L., Bradley L., Smith A., and Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 172 (2004) 567-576
39. Busso N., So A., Chobaz-Peclat V., Morard C., Martinez-Soria E., Talabot-Ayer D., et al. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168 (2002) 875-882
40. Siegmund B., Sennello J.A., Jones-Carson J., Gamboni-Robertson F., Lehr H.A., Batra A., et al. Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut 53 (2004) 965-972
41. Barbier M., Cherbut C., Aube A.C., Blottiere H.M., and Galmiche J.P. Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut 43 (1998) 783-790
42. Tuzun A., Uygun A., Yesilova Z., Ozel A.M., Erdil A., Yaman H., et al. Leptin levels in the acute stage of ulcerative colitis. J Gastroenterol Hepatol 19 (2004) 429-432
43. Matarese G., Carrieri P.B., La Cava A., Perna F., Sanna V., De Rosa V., et al. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. Proc Natl Acad Sci 102 (2005) 5150-5155
44. Matarese G., Di Giacomo A., Sanna V., Lord G.M., Howard J.K., Di Tuoro A., et al. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 166 (2001) 5909-5916
45. Fantuzzi G., Sennello J.A., Batra A., Fedke I., Lehr H.A., Zeitz M., et al. Defining the role of T cell-derived leptin in the modulation of hepatic or intestinal inflammation in mice. Clin Exp Immunol 142 (2005) 31-38
46. Matarese G., Sanna V., Lechler R.I., Sarvetnick N., Fontana S., Zappacosta S., et al. Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 51 (2002) 1356-1361
47. Palmer G., Aurrand-Lions M., Contassot E., Talabot-Ayer D., Ducrest-Gay D., Vesin C., et al. Indirect effects of leptin receptor deficiency on lymphocyte populations and immune response in db/db mice. J Immunol 177 5 (2006) 2899-2907 Sep 1
48. Canavan B., Salem R.O., Schurgin S., Koutkia P., Lipinska I., Laposata M., et al. Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation. J Clin Endocrinol Metab 90 (2005) 5779-5785
49. Sennello J.A., Fayad R., Morris A.M., Eckel R.H., Asilmaz E., Montez J., et al. Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin. Endocrinology 146 (2005) 2157-2164
50. Fraser D.A., Thoen J., Reseland J.E., Forre O., and Kjeldsen-Kragh J. Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol 18 (1999) 394-401
51. Otero M., Lago R., Gomez R., Lago F., Dieguez C., Gomez-Reino J.J., et al. Changes in fat-derived hormones plasma concentrations: adiponectin, leptin, resistin and visfatin in rheumatoid arthritis subjects. Ann Rheum Dis 65 9 (2006) 1198-1201
52. Bokarewa M., Bokarew D., Hultgren O., and Tarkowski A. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 62 (2003) 952-956
53. Goldring M.B. The role of the chondrocyte in osteoarthritis. Arthritis Rheum 43 (2000) 1916-1926
54. Goldring M.B., and Berenbaum F. The regulation of chondrocyte function by pro-inflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res 427 (2004) 37-46
55. Dumond H., Presle N., Terlain B., Mainard D., Loeuille D., Netter P., et al. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 48 (2003) 3118-3129
56. Teichtahl A.J., Wluka A.E., Proietto J., and Cicuttini F.M. Obesity and the female sex, risk factors for knee osteoarthritis that may be attributable to systemic or local leptin biosynthesis and its cellular effects. Med Hypotheses 65 (2005) 312-315
57. Otero M., Gomez Reino J.J., and Gualillo O. Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis Rheum 48 (2003) 404-409
58. Otero M., Lago R., Lago F., Reino J.J., and Gualillo O. Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Res Ther 7 (2005) 581-591
59. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., and Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116 7 (2006) 1784-1792
60. Ronti T., Lupattelli G., and Mannarino E. The endocrine role of adipose tissue: an update. Clin Endocrinol 64 (2006) 355-365
61. Berg A.H., and Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96 9 (2005) 939-949
62. Whitehead J.P., Richards A.A., Hickman I.J., MacDonald G.A., and Prins J.B. Adiponectin a key adipokine in the metabolic syndrome. Diab Obes Metab 8 (2006) 264-280
63. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 26 (2005) 439-451
64. Tan K.C., Xu C., Chow W.S., Lam M.C., Ai V.H., Tam S.C., et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89 (2004) 760-765
65. Fasshuer M., Kralish S., Klier M., Lossner U., Bluher M., Klein J., et al. Adiponectin gene expression and secretion is inhibited by IL-6 in 3T3-L1 adipocytes. Biochem Biophys Res Comm 301 (2003) 1045-1050
66. Bruun J.M., Lihn A.S., Verdich C., Pedersen S.B., Toubro S., Astrup A., et al. Regulation of adiponectin by adipose tissue derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285 (2003) E527-E533
67. Takemura Y., Ouchi N., Shibata R., Aprahamian T., Kirber M.T., Summer R.S., et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest (2007, 25 January) 10.1172/JCI29709
68. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50 9 (2001) 2094-2099
69. Funahashi T., Nakamura T., Shimomura I., Maeda K., Kuriyama H., Takahashi M., et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 38 2 (1999) 202-206
70. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 14 (2004) 1730-1737
71. Ehling A., Schaffler A., Herfarth H., Tarner I.H., Anders S., Distler O., et al. The potential of adiponectin in driving arthritis. J Immunol 176 7 (2006) 4468S-4478S
72. Schaffler A., Ehling A., Neumann E., Herfarth H., Paul G., Tarner I., et al. Adipocytokines in synovial fluid. JAMA 290 (2003) 1709-1710
73. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115 5 (2005) 911-919
74. Xu A., Wang Y., Keshaw H., Xu L.Y., Lam K.S., and Cooper G.J. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112 1 (2003) 91-100
75. Kamada Y., Tamura S., Kiso S., Matsumoto H., Saji Y., Yoshida Y., et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 125 6 (2003) 1796-1807
76. Masaki T., Chiba S., Tatsukawa H., Yasuda T., Noguchi H., Seike M., et al. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology 40 1 (2004) 177-184
77. Housa D., Housova J., Vernerova Z., and Haluzik M. Adipocytokines and cancer. Physiol Res 55 3 (2006) 233-244
78. Kato H., Kashiwagi H., Shiraga M., Tadokoro S., Kamae T., Ujiie H., et al. Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol 26 1 (2006) 224-230
79. Holcomb I.N., Kabakoff R.C., Chan B., Baker T.W., Gurney A., Henzel W., et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19 15 (2000) 4046-4055
80. Rajala M.W., Obici S., Scherer P.E., and Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 111 2 (2003) 225-230
81. Gerstmayer B., Kusters D., Gebel S., Muller T., Van Miert E., Hofmann K., et al. Identification of RELM gamma, a novel resistin-like molecule with a distinct expression pattern. Genomics 81 6 (2003) 588-595
82. Koerner A., Kratzsch J., and Kiess W. Adipocytokines: leptin - the classical. Resistin - the controversical, adiponectin - the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19 (2005) 525-546
83. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 409 6818 (2001) 307-312
84. Pang S., and Le Y. Role of Resistin in inflammation and inflammation related diseases. Cell Mol Immunol 3 1 (2006) 29-34
85. Bokarewa M., Nagaev I., Dahlberg L., Smith U., and Tarkowski A. Resistin an adipokine with potent pro-inflammatory properties. J Immunol 174 9 (2005) 5789-5795
86. Lehrke M., Reilly M.P., Millington S.C., Iqbal N., Rader D.J., and Lazar M.A. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1 2 (2004) e45
87. Harsch I.A., Koebnick C., Wallaschofski H., Schahin S.P., Hahn E.G., Ficker J.H., et al. Resistin levels in patients with obstructive sleep apnoea syndrome-the link to subclinical inflammation?. Med Sci Monit 10 9 (2004) CR510-CR515
88. Reilly M.P., Lehrke M., Wolfe M.L., Rohatgi A., Lazar M.A., and Rader D.J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111 7 (2005) 932-939
89. Verma S., Li S.H., Wang C.H., Fedak P.W., Li R.K., Weisel R.D., et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108 6 (2003) 736-740
90. Kawanami D., Maemura K., Takeda N., Harada T., Nojiri T., Imai Y., et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 314 2 (2004) 415-419
91. Burnett M.S., Lee C.W., Kinnaird T.D., Stabile E., Durrani S., Dullum M.K., et al. The potential role of resistin in atherogenesis. Atherosclerosis 182 2 (2005) 241-248
92. Senolt L., Housa D., Vernerova Z., Jirasek T., Svobodova R., Veigl D., et al. Resistin is abundantly present in rheumatoid arthritis synovial tissue, synovial fluid, and elevated serum resistin reflects disease activity. Ann Rheum Dis 66 4 (2007) 458-463
93. Schaffler A., Ehling A., Neumann E., Herfarth H., Tarner I., Scholmerich J., et al. Adipocytokines in synovial fluid. JAMA 290 13 (2003) 1709-1710
94. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307 5708 (2005) 426-430
95. Jia S.H., Li Y., Parodo J., Kapus A., Fan L., Rotstein O.D., et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113 9 (2004) 1318-1327
96. Moschen A.R., Kaser A., Enrich B., Mosheimer B., Theurl M., Niederegger H., et al. Visfatin an adipocytokine with pro-inflammatory and immunomodulating properties. J Immunol 178 3 (2007) 1748-1758
97. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M.X., et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251 (1998) 471-476
98. Boucher J., Masri B., Daviaud D., Gesta S., Guigné C., Mazzucotelli A., et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146 (2005) 1764-1771
99. Daviaud D., Boucher J., Gesta S., Dray C., Guigne C., Quilliot D., et al. TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J 20 9 (2006) 1528-1530
100. Heinonen M.V., Purhonen A.K., Miettinen P., Paakkonen M., Pirinen E., Alhava E., et al. Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regul Pept 130 (2005) 7-13
101. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112 (2003) 1821-1830
102. Hida K., Wada J., Eguchi J., Zhang H., Baba M., Seida A., et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 102 (2005) 10610-10615
103. Kloting N., Berndt J., Kralisch S., Kovacs P., Fasshauer M., Schon M.R., et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 339 1 (2006) 430-436
104. Park C.H., Valore E.V., Waring A.J., and Ganz T. Hepcidin a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276 (2001) 7806-7810
105. Bekri S., Gual P., Anty R., Luciani N., Dahman M., Ramesh B., et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131 3 (2006) 788-796
106. Fleming R.E., and Sly W.S. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci U S A 98 (2001) 8160-8162
107. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., and Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101 (2003) 2461-2463
108. Ganz T. Hepcidin: a peptide hormone at the interface of innate immunity and iron metabolism. Curr Top Microbiol Immunol 306 (2006) 183-198